Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
Asbestos hidden for decades in talcum powder products made by Johnson & Johnson and Colgate-Palmolive gave a 61-year-old woman mesothelioma, leaving her only months to live, her attorney told a California jury Monday on the first day of trial.
The government has urged a California federal court to pause a civil suit against a former Theranos Inc. executive amid related pending criminal proceedings in which the ex-leader of the wannabe bloodwork disruptor faces charges over some of the same conduct.
Johnson & Johnson has agreed to pay $9.9 million to settle the state of Washington’s allegations that its Ethicon subsidiary downplayed the risks of its surgical mesh devices in its marketing, avoiding a Seattle trial that was about to begin Monday.
A proposed class action accusing embattled Aveo Pharmaceuticals Inc., its CEO and two others of misleading investors ahead of a sharp January stock drop was moved to Massachusetts federal court Monday after the company's unopposed bid to transfer the suit from New York.
Dassault Systèmes is looking for stateside acquisitions, Cerberus Capital Management is looking to raise $2.5 billion with a new direct lending-focused fund and Bain Capital is looking at options for technology company Waystar.